Vericel Corp. | $VCEL Stock | Shares Surge Over 80% on FDA Approval

By |December 14th, 2016|

Vericel Corp. (NASDAQ: VCEL)
Vericel Corp Spikes On News Of FDA Approval
On Wednesday before the market opened, shares of VCEL, a leading developer in autologous cell therapies, were being bought up on volume following the announcement that the Food & Drug Administration (FDA) has approved MACI for the treatment of symptomatic cartilage defects in the […]